IMPROVEMENT in ERADICATION of H-PYLORI INFECTION
Helicobacter Pylori Infection
About this trial
This is an interventional treatment trial for Helicobacter Pylori Infection focused on measuring Lactobacillus reuteri, Helicobacter pylori, Dyspepsia, Eradication Therapy
Eligibility Criteria
Inclusion Criteria: Patients between 18 years to 60 years of age. Either gender Patients having H. pylori related chronic gastritis with/without peptic ulcers on endoscopy & gastric biopsy (histopathology) or Stool for H. pylori antigen +ve , or Rapid urease test +ve Exclusion Criteria: Pregnant women End stage renal disease (GFR <15 mL/min/) Chronic Liver Disease
Sites / Locations
- Mehreen Akmal
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
ERADICATION of H-PYLORI INFECTION with ADDITION of LACTOBACILLUS REUTERI
ERADICATION of H-PYLORI INFECTION without LACTOBACILLUS REUTERI
In experimental group, patients receiving clarithromycin based sequential therapy with LACTOBACILLUS REUTERI
control group included patients who received clarithromycin based sequential therapy alone